Coral Genomics

What we do? We develop digital therapeutics to address unmet medical needs in hematology and oncology. How it works? First we build networks of doctors and patients designed to track, predict and prevent disease. Second, we validate the safety and efficacy of our interventions in pivotal clinical studies to obtain regulatory clearance (SaMD). Finally, we aim to commercialize our products as prescription digital therapeutics (DTx). Where are we now? Today, we are the standard in digital hematolog

shared extracted concept terms: unmet, medical, need; shared product terms: clinical, predict, disease, patient; shared product theme: health and clinical care; shared affiliation: Y Combinator

Keylika is an early stage biopharma startup developing metal-based drugs using a platform synthesis technology to treat unmet medical needs. We then administer these drugs using proven delivery technologies to effect the best clinical outcomes. Our first product is a small molecule iron drug (new molecular entity) delivered by a wearable skin patch to treat Iron Deficiency Anemia (IDA), with significantly higher safety, efficacy and tolerability over existing treatments. This is poised to be a b

shared extracted concept terms: unmet, medical, need; shared product terms: molecular, clinical, treatment, unmet; shared product theme: health and clinical care; shared affiliation: Y Combinator

Junction Bioscience is building an autonomous AI scientist to navigate the discovery of transformative medicines. Our scientific hypothesis engine iterates upon breakthrough chemistry from the laboratory to achieve clarity and control over the molecular basis of disease. We focus on the intersection of neuroinflammation and immunology where uncommon molecular insights position us to develop best-in-class therapies for millions of patients in need.

shared extracted concept terms: need, patient; shared product terms: molecular, laboratory, disease, patient; shared product theme: health and clinical care; shared affiliation: Y Combinator

Auricle is a medical device company building a breakthrough neurostimulation implant to restore hearing in millions of patients who no longer benefit from hearing aids, get less than 60% on a word recognition test, but aren't prepared to make the jump to a cochlear implant. Our approach preserves remaining natural hearing through a reversible and less invasive surgery, addressing the key concerns that hold most patients back from getting a cochlear implant (currently the only treatment option fo

shared extracted concepts: patients; shared product terms: medical, patient, who, test; shared product theme: health and clinical care; shared affiliation: Y Combinator

For clinical trials struggling to find eligible patients, and for medical patients looking for alternative treatment, Third Opinion increases access and efficiency in clinical trial enrollment.

shared extracted concept terms: medical, patient; shared product terms: clinical, treatment, patient, medical; shared product theme: health and clinical care

We are an African genomics research, services and development company addressing the need to include under-represented African genomic data in research which could lead to medical breakthroughs and new healthcare solutions worldwide.

shared extracted concept terms: medical; shared product terms: genomic, address, need, medical; shared product theme: health and clinical care; shared affiliation: Y Combinator